# Alterity Therapeutics Ltd: financial statements, quarterly

ATHE · Nasdaq · CIK 1131343 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/athe.md) · [Financials](/companies/athe/financials.md) · [Filings](/companies/athe/filings.md) · [Insiders](/companies/athe/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/athe/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2015-06-30) | period not labelled (2016-06-30) | period not labelled (2017-06-30) | FY2018 (2018-06-30) | FY2019 (2019-06-30) | FY2020 (2020-06-30) | FY2021 (2021-06-30) | FY2022 (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [34.9](/filings/0001144204-18-047425.md) | [28.6](/filings/0001213900-19-016984.md) | [21.9](/filings/0001213900-20-026557.md) | [15.2](/filings/0001213900-21-046254.md) | [14.4](/filings/0001213900-22-052529.md) | [9.2](/filings/0001213900-23-072629.md) | [28.1](/filings/0001213900-24-082281.md) | [34.8](/filings/0001213900-25-082027.md) | [15.8](/filings/0001213900-25-082027.md) | [12.6](/filings/0001213900-25-082027.md) | [33.2](/filings/0001213900-25-082027.md) |
| Current assets | $m | not reported | not reported | [25.3](/filings/0001144204-18-047425.md) | [18.7](/filings/0001213900-19-016984.md) | [19.9](/filings/0001213900-20-026557.md) | [9.8](/filings/0001213900-21-046254.md) | [33.5](/filings/0001213900-22-052529.md) | [41.1](/filings/0001213900-23-072629.md) | [27.0](/filings/0001213900-24-082281.md) | [19.0](/filings/0001213900-25-082027.md) | [45.9](/filings/0001213900-25-082027.md) |
| Total assets | $m | not reported | not reported | [25.3](/filings/0001144204-18-047425.md) | [18.7](/filings/0001213900-19-016984.md) | [19.9](/filings/0001213900-20-026557.md) | [9.9](/filings/0001213900-21-046254.md) | [33.6](/filings/0001213900-22-052529.md) | [41.4](/filings/0001213900-23-072629.md) | [27.3](/filings/0001213900-24-082281.md) | [19.2](/filings/0001213900-25-082027.md) | [46.0](/filings/0001213900-25-082027.md) |
| Current liabilities | $m | not reported | not reported | [1.6](/filings/0001144204-18-047425.md) | [2.6](/filings/0001213900-19-016984.md) | [3.3](/filings/0001213900-20-026557.md) | [2.7](/filings/0001213900-21-046254.md) | [3.1](/filings/0001213900-22-052529.md) | [5.8](/filings/0001213900-23-072629.md) | [4.4](/filings/0001213900-24-082281.md) | [5.4](/filings/0001213900-25-082027.md) | [3.5](/filings/0001213900-25-082027.md) |
| Total liabilities | $m | not reported | not reported | [1.6](/filings/0001144204-18-047425.md) | [2.6](/filings/0001213900-19-016984.md) | [3.4](/filings/0001213900-20-026557.md) | [2.8](/filings/0001213900-21-046254.md) | [3.1](/filings/0001213900-22-052529.md) | [5.9](/filings/0001213900-23-072629.md) | [4.5](/filings/0001213900-24-082281.md) | [5.4](/filings/0001213900-25-082027.md) | [3.6](/filings/0001213900-25-082027.md) |
| Shareholders' equity | $m | [39.1](/filings/0001144204-18-047425.md) | [31.4](/filings/0001213900-19-016984.md) | [23.7](/filings/0001213900-20-026557.md) | [16.1](/filings/0001213900-21-046254.md) | [16.6](/filings/0001213900-22-052529.md) | [7.2](/filings/0001213900-23-072629.md) | [30.5](/filings/0001213900-24-082281.md) | [35.5](/filings/0001213900-25-082027.md) | [(195)](/filings/0001213900-24-082281.md) | [(214)](/filings/0001213900-25-082027.md) | [(226)](/filings/0001213900-25-082027.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 217,508,862 at 2026-06-30, from the cover of the [20-F filed 2026-08-28](/filings/0001437749-26-029135.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.